Hino B, Eliakim R, Levine A, Sprecher H, Berkowitz D, Hartman C, Eshach-Adiv O, Shamir Raanan
Pediatric Gastroenterology and Nutrition, Meyer Children's Hospital of Haifa, Haifa, Israel.
J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):519-23. doi: 10.1097/00005176-200411000-00013.
There are few reports which the tests used for diagnosing Helicobacter pylori infection and monitoring its eradication in children.
Prospective evaluation of invasive (gastric histology, rapid urease test [RUT]) and non-invasive (stool antigen [FemtoLab H. pylori], urea breath test [UBT]) tests in the diagnosis of H. pylori infection and post-treatment eradication in children and adolescents.
Ninety-two patients (50 male, 42 female) referred for upper gastrointestinal endoscopy were prospectively enrolled. UBT was performed and stool specimens collected for monoclonal enzyme immunoassay for H. pylori antigen (FemtoLab) 1 to 4 days before endoscopy. H. pylori in gastric biopsies was evaluated by RUT and staining with hematoxylin-eosin and giemsa. Eradication therapy was given to children with abdominal pain and H. pylori gastritis. FemtoLab H. pylori and UBT were repeated 6 weeks after the end of triple therapy.
Histology identified H. pylori in 49 of 92 (53%) subjects. Concordance between histology and RUT was found in 78 of 92 children. FemtoLab H. pylori was positive in 41 of 78 (52.6%) children with sensitivity, specificity, positive and negative predictive values of 97.5%, 94.7%, 95.1% and 97.3%, respectively. For UBT, these values were 100%, 96.9%, 97.5% and 100%, respectively. Twenty-six of 36 patients who received triple therapy returned for eradication evaluation. Tests for H. pylori antigen in stool were positive in 10 of 26 and for UBT in 11 of 26.
Stool antigen (FemtoLab) and UBT were equally effective in diagnosing and confirming eradication of H. pylori infection in children.
关于用于诊断儿童幽门螺杆菌感染及监测其根除情况的检测方法的报道较少。
前瞻性评估侵入性检测(胃组织学检查、快速尿素酶试验[RUT])和非侵入性检测(粪便抗原[FemtoLab幽门螺杆菌检测]、尿素呼气试验[UBT])在儿童及青少年幽门螺杆菌感染诊断及治疗后根除情况监测中的应用。
前瞻性纳入92例因上消化道内镜检查而转诊的患者(50例男性,42例女性)。在内镜检查前1至4天进行尿素呼气试验,并采集粪便标本进行幽门螺杆菌抗原的单克隆酶免疫测定(FemtoLab)。通过快速尿素酶试验以及苏木精-伊红和吉姆萨染色评估胃活检组织中的幽门螺杆菌。对有腹痛和幽门螺杆菌胃炎的儿童给予根除治疗。三联疗法结束6周后重复进行FemtoLab幽门螺杆菌检测和尿素呼气试验。
组织学检查在92例受试者中的49例(53%)中发现幽门螺杆菌。92例儿童中78例的组织学检查和快速尿素酶试验结果一致。78例儿童中41例(52.6%)的FemtoLab幽门螺杆菌检测呈阳性,其敏感性、特异性、阳性预测值和阴性预测值分别为97.5%、94.7%、95.1%和97.3%。对于尿素呼气试验,这些值分别为100%、96.9%、97.5%和100%。接受三联疗法的36例患者中有26例返回进行根除评估。粪便中幽门螺杆菌抗原检测在26例中的10例呈阳性,尿素呼气试验在26例中的11例呈阳性。
粪便抗原(FemtoLab)和尿素呼气试验在诊断及确认儿童幽门螺杆菌感染的根除情况方面同样有效。